858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune response.

Biotechnology

Education

858 Therapeutics

858 Therapeutics' headquarters in San Diego, CA, United States

Jeffrey Stafford

Umi Chong

Kimberly R.

Jim Veal

Sanjay Trehan

James Veal

Schraga Schwartz

Clare Ozawa

Michael G. Kharas

Ali Behbahani

Carlo Rizzuto

Samie Jaffrey

Jane Huang

The Program Management team at 858 Therapeutics is responsible for overseeing the strategic planning and execution of drug development programs in oncology. They ensure that projects are aligned with the company's goals, manage timelines and budgets, and facilitate cross-functional collaboration among research, finance, and HR teams to drive innovation and operational efficiency.

Program Management

The Biology and Life Sciences team at 858 Therapeutics focuses on advancing the company's drug discovery initiatives by leveraging expertise in molecular biology, medicinal chemistry, and computational biology. This multidisciplinary team collaborates to identify and validate novel therapeutic targets in oncology, develop small molecule compounds, and translate scientific insights into effective treatments that modulate RNA regulation and the innate immune response.

Biology and Life Sciences

The Research and Development team at 858 Therapeutics focuses on discovering and optimizing small molecule drugs aimed at innovative therapeutic targets in oncology. This multidisciplinary group, comprising senior scientists and research associates, engages in cutting-edge research to uncover new insights into protein functions that regulate RNA and the innate immune response, ultimately driving the discovery of effective treatments for cancer.

Research and Development

The Leadership Team at 858 Therapeutics drives the strategic vision and overarching goals of the company, guiding the development of innovative small molecule drugs in oncology. Comprised of key executives such as the CEO and Chief Scientific Officers, this team oversees research initiatives, fosters collaboration across departments, and ensures alignment with the company's mission to target novel therapeutic pathways. They are instrumental in making high-level decisions that impact the company's direction and growth in the competitive biotech landscape.

��

858 Therapeutics

Org chart

Board & advisors

Teams

Program Management

Biology and Life Sciences

Research and Development

Leadership Team

Offices

��������

858 Therapeutics

Org chart

Board & advisors

Teams

Program Management

Biology and Life Sciences

Research and Development

Leadership Team

Offices

Related companies

��